SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Mar 7 3:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (37)12/3/1996 12:56:00 PM
From: harry zelatis   of 965
 
To all, Centocor may have its glory day today but keep in mind that Corr Therapeutics has Integrelin,a similar drug to REPRO. I have seen this many times where investors are blinded by greed. Integrelin is supposed to get FDA review on June 1, 1997. If the data comes out to be statistically significant then Corr's stock will increase in the same magnitude as Centocor's. Centocor's stock will decrease because integrelin will be much cheaper and may even capture the majority of the market thus hurting Centocor's future revenue growth.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News